Fig 1.
Flowchart for patient and control group inclusion and primary outcome.
Table 1.
Characteristics of patients prescribed antiepileptic drugs according to enzyme inhibiting profile and age- and gender-matched controls.
Fig 2.
Low energy fracture-free probability over time in relation to type of antiepileptic drug, compared to controls for men (left) and women (right), respectively.
Fig 3.
Low energy fracture-free probability over time in relation to being prescribed antiepileptic drugs and having a registered epilepsy diagnosis or not, compared to controls for men (left) and women (right), respectively.
Table 2.
Results from Cox proportional hazard regression regarding risks for low energy fractures, analysed for the total cohort.
Fig 4.
Chart displaying relative low energy fracture risks (as hazard rate ratios) during the follow-up period in relation to the five risk factors (gender, age, epilepsy diagnosis, type of antiepileptic drugs and BMI).
Age group is the age of the patient’s first entry in the EHR.
Fig 5.
Low energy fracture-free probability over time in relation to KEFRI-value (quartiles).